Concepedia

Jay Ji

JJ

Statistics

Publications

6

Citations

151

H-Index

6

Active since

2001

Affiliations

Barrow Neurological Institute(Current)

Jay Ji is an author at Barrow Neurological Institute specializing in pharmacology, oncology, and life sciences.

Publications per year

2001–2011

6

Publications

6

Identification and functional characterization of a novel ryanodine receptor mutation causing malignant hyperthermia in North American and South American families

Nyamkhishig Sambuughin, Thomas E. Nelson, Joseph Jankovic et al. · Neuromuscular Disorders · 2001 · 50 citations

, , +7

A phase I combination study of olaparib (AZD2281; KU-0059436) and cisplatin (C) plus gemcitabine (G) in adults with solid tumors.

Giuseppe Giaccone, Aditya Rajan, Ronan J. Kelly et al. · Journal of Clinical Oncology · 2010 · 37 citations

, , +14

Phase I study of the safety, pharmacokinetics (PK), and pharmacodynamics (PD) of the poly(ADP-ribose) polymerase (PARP) inhibitor veliparib (ABT-888; V) in combination with irinotecan (CPT-11; Ir) in patients (pts) with advanced solid tumors.

P. LoRusso, Jay Ji, J. Li et al. · Journal of Clinical Oncology · 2011 · 27 citations

, , +16

Tired of the same old grind in the new genomics and proteomics era?

Patricia E. Garrett, Nathan P. Lawrence, Jay Ji et al. · TARGETS · 2002 · 14 citations

, , +9

Pharmacodynamic response in phase I combination study of ABT-888 and topotecan in adults with refractory solid tumors and lymphomas.

Jay Ji, Shivaani Kummar, A. P. Chen et al. · Journal of Clinical Oncology · 2010 · 13 citations

, , +16

1–5 of 6